GOCO PE Ratio & Valuation,Is GOCO Overvalued

GOCO Relative Valuation

GOCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GOCO is overvalued; if below, it's undervalued.

Historical Valuation

Gohealth Inc (GOCO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.18 is considered Fairly compared with the five-year average of -16.59. The fair price of Gohealth Inc (GOCO) is between 0.86 to 6.31 according to relative valuation methord.

Relative Value

Fair Zone

0.86-6.31

Current Price：2.36

Fair

-0.30

-8.65

EV/EBITDA

Gohealth Inc. (GOCO) has a current EV/EBITDA of -8.65. The 5-year average EV/EBITDA is 10.00. The thresholds are as follows: Strongly Undervalued below -5.67, Undervalued between -5.67 and 2.16, Fairly Valued between 17.84 and 2.16, Overvalued between 17.84 and 25.67, and Strongly Overvalued above 25.67. The current Forward EV/EBITDA of -8.65 falls within the Strongly Undervalued range.

-4.56

EV/EBIT

Gohealth Inc. (GOCO) has a current EV/EBIT of -4.56. The 5-year average EV/EBIT is -2.62. The thresholds are as follows: Strongly Undervalued below -112.53, Undervalued between -112.53 and -57.58, Fairly Valued between 52.33 and -57.58, Overvalued between 52.33 and 107.28, and Strongly Overvalued above 107.28. The current Forward EV/EBIT of -4.56 falls within the Historic Trend Line -Fairly Valued range.

0.18

Gohealth Inc. (GOCO) has a current PS of 0.18. The 5-year average PS is 0.26. The thresholds are as follows: Strongly Undervalued below -0.26, Undervalued between -0.26 and 0.00, Fairly Valued between 0.53 and 0.00, Overvalued between 0.53 and 0.79, and Strongly Overvalued above 0.79. The current Forward PS of 0.18 falls within the Historic Trend Line -Fairly Valued range.

-6.99

P/OCF

Gohealth Inc. (GOCO) has a current P/OCF of -6.99. The 5-year average P/OCF is 2.40. The thresholds are as follows: Strongly Undervalued below -15.68, Undervalued between -15.68 and -6.64, Fairly Valued between 11.44 and -6.64, Overvalued between 11.44 and 20.48, and Strongly Overvalued above 20.48. The current Forward P/OCF of -6.99 falls within the Undervalued range.

-1.04

P/FCF

Gohealth Inc. (GOCO) has a current P/FCF of -1.04. The 5-year average P/FCF is 3.13. The thresholds are as follows: Strongly Undervalued below -21.24, Undervalued between -21.24 and -9.06, Fairly Valued between 15.31 and -9.06, Overvalued between 15.31 and 27.49, and Strongly Overvalued above 27.49. The current Forward P/FCF of -1.04 falls within the Historic Trend Line -Fairly Valued range.

Gohealth Inc (GOCO) has a current Price-to-Book (P/B) ratio of 0.56. Compared to its 3-year average P/B ratio of 0.54 , the current P/B ratio is approximately 4.82% higher. Relative to its 5-year average P/B ratio of 0.79, the current P/B ratio is about -28.75% higher. Gohealth Inc (GOCO) has a Forward Free Cash Flow (FCF) yield of approximately -203.85%. Compared to its 3-year average FCF yield of -0.40%, the current FCF yield is approximately 50337.99% lower. Relative to its 5-year average FCF yield of -62.41% , the current FCF yield is about 226.64% lower.

0.56

P/B

Median3y

0.54

Median5y

0.79

-203.85

FCF Yield

Median3y

-0.40

Median5y

-62.41

Competitors Valuation Multiple

The average P/S ratio for GOCO's competitors is 0.27, providing a benchmark for relative valuation. Gohealth Inc Corp (GOCO) exhibits a P/S ratio of 0.18, which is -34.16% above the industry average. Given its robust revenue growth of -71.10%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of GOCO decreased by 86.01% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from 0.00 to -0.14.

The secondary factor is the Revenue Growth, contributed -71.10%to the performance.

Overall, the performance of GOCO in the past 1 year is driven by P/E Change. Which is more unsustainable.

-71.10%

118.29M → 34.19M

Revenue Growth

-7168.98%

12.99 → -918.26

Margin Expansion

7154.07%

0.00 → -0.14

P/E Change

-86.01%

16.30 → 2.28

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Gohealth Inc (GOCO) currently overvalued or undervalued?

What is Gohealth Inc (GOCO) fair value?

GOCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Gohealth Inc (GOCO) is between 0.86 to 6.31 according to relative valuation methord.

How does GOCO's valuation metrics compare to the industry average?

What is the current P/B ratio for Gohealth Inc (GOCO) as of Jan 08 2026?

As of Jan 08 2026, Gohealth Inc (GOCO) has a P/B ratio of 0.56. This indicates that the market values GOCO at 0.56 times its book value.

What is the current FCF Yield for Gohealth Inc (GOCO) as of Jan 08 2026?

As of Jan 08 2026, Gohealth Inc (GOCO) has a FCF Yield of -203.85%. This means that for every dollar of Gohealth Inc’s market capitalization, the company generates -203.85 cents in free cash flow.

What is the current Forward P/E ratio for Gohealth Inc (GOCO) as of Jan 08 2026?

As of Jan 08 2026, Gohealth Inc (GOCO) has a Forward P/E ratio of -0.30. This means the market is willing to pay $-0.30 for every dollar of Gohealth Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Gohealth Inc (GOCO) as of Jan 08 2026?

As of Jan 08 2026, Gohealth Inc (GOCO) has a Forward P/S ratio of 0.18. This means the market is valuing GOCO at $0.18 for every dollar of expected revenue over the next 12 months.

GOCO Valuation